跳至主要内容
临床试验/JPRN-UMIN000038269
JPRN-UMIN000038269已完成未知

The efficacy of Fesoterodine for the treatment of neurogenic detrusor overactivity and/or low-compliance bladder - The efficacy of Fesoterodine for the treatment of neurogenic detrusor overactivity and/or low-compliance bladder

Dokkyo Medical University0 个研究点目标入组 77 人开始时间: 2020年3月31日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
77

研究概览

简要总结

A total of 17 patients withdrew because of adverse events and so on. 60 patients completed the study. Bladder capacity at first desire to void, maximum cystometric capacity and bladder compliance increased significantly. Neurogenic detrusor overactivity disappeared in 23.5%, and a significant increase was observed in bladder capacity at first involuntary contraction, and a significant decrease was observed in maximum detrusor contraction.

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 100years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Genitourinary tract anomalies, acute infection of the genitourinary tract or clinical relevant diseases of the kidneys; and any condition that in the opinion of the investigator made the patient unsuitable for the study.

研究者

相似试验